Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 12.5% in the morning session after Peter Marks, the ...

Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The steep decline comes as the S&P 500 and Nasdaq Composite lost 0.4% ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, ...

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...

Key Takeaways The S&P 500 and Nasdaq lost ground at midday as the Trump administration's reciprocal tariffs are set to kick ...

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 10 unusual trades. Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies.

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...